Increased laforin and laforin binding to glycogen underlie lafora body formation in malin-deficient lafora disease

Journal of Biological Chemistry

Volumn 287, Issue 30, 2012, Pages 25650-25659

  Tiberia, Erica ^a   Turnbull, Julie ^a,b   Wang, Tony ^a   Ruggieri, Alessandra ^a   Zhao, Xiao Chu ^a   Pencea, Nela ^a   Israelian, Johan ^a   Wang, Yin ^c   Ackerley, Cameron A ^b   Wang, Peixiang ^a   Liu, Yan ^c   Minassian, Berge A ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; MAMMALS;

DEPHOSPHORYLATES; NEURODEGENERATIVE; PHOSPHATE IONS; PROTEASOMAL DEGRADATION; UBIQUITIN LIGASES;

NEURODEGENERATIVE DISEASES;

CELL PROTEIN; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; LAFORIN; MALIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; GLYCOGEN SYNTHESIS; HYDROPHOBICITY; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LOSS OF FUNCTION MUTATION; MYOCLONUS EPILEPSY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; WESTERN BLOTTING;

MUS;

EID: 84864102123     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.331611     Document Type: Article

References (40)

1. Roach, P. J. (2002) Glycogen and its metabolism. Curr. Mol. Med. 2, 101-120
2. Tagliabracci, V. S., Girard, J. M., Segvich, D., Meyer, C., Turnbull, J., Zhao, X., Minassian, B. A., Depaoli-Roach, A. A., and Roach, P. J. (2008) Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J. Biol. Chem. 283, 33816-33825
3. Tagliabracci, V. S., Heiss, C., Karthik, C., Contreras, C. J., Glushka, J., Ishihara, M., Azadi, P., Hurley, T. D., DePaoli-Roach, A. A., and Roach, P. J. (2011) Phosphate incorporation during glycogen synthesis and Lafora disease. Cell Metab. 13, 274-282
4. Wang, J., Stuckey, J. A., Wishart, M. J., and Dixon, J. E. (2002) A unique carbohydrate-binding domain targets the Lafora disease phosphatase to glycogen. J. Biol. Chem. 277, 2377-2380 (Pubitemid 34953257)
5. Worby, C. A., Gentry, M. S., and Dixon, J. E. (2006) Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates. J. Biol. Chem. 281, 30412-30418 (Pubitemid 44582097)
6. Ceulemans, H., and Bollen, M. (2004) Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84, 1-39 (Pubitemid 38049874)
7. Andersen, D. H. (1956) Familial cirrhosis of the liver with storage of abnormal glycogen. Lab. Invest. 5, 11-20
8. Bao, Y., Kishnani, P., Wu, J. Y., and Chen, Y. T. (1996) Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen branching enzyme gene. J. Clin. Invest. 97, 941-948 (Pubitemid 26070573)
9. Brown, B. I., and Brown, D. H. (1966) Lack of an α-1,4-glucan: α-1,4-glucan 6-glycosyltransferase in a case of type IV glycogenosis. Proc. Natl. Acad. Sci. U.S.A. 56, 725-729
10. Schochet, S. S., Jr., McCormick, W. F., and Zellweger, H. (1970) Type IV glycogenosis (amylopectinosis). Light and electron microscopic observations. Arch. Pathol. 90, 354-363
11. Minassian, B. A. (2001) Lafora disease: towards a clinical, pathologic, and molecular synthesis. Pediatr. Neurol. 25, 21-29
12. Minassian, B. A., Lee, J. R., Herbrick, J. A., Huizenga, J., Soder, S., Mungall, A. J., Dunham, I., Gardner, R., Fong, C. Y., Carpenter, S., Jardim, L., Satishchandra, P., Andermann, E., Snead, O. C., 3rd, Lopes-Cendes, I., Tsui, L. C., Delgado-Escueta, A. V., Rouleau, G. A., and Scherer, S. W. (1998) Mutations in a gene encoding a novel protein-tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 20, 171-174 (Pubitemid 28455450)
13. Robitaille, Y., Carpenter, S., Karpati, G., and DiMauro, S. D. (1980) A distinct form of adult polyglucosan body disease with massive involvement of central and peripheral neuronal processes and astrocytes: a report of four cases and a review of the occurrence of polyglucosan bodies in other conditions such as Lafora disease and normal ageing. Brain 103, 315-336 (Pubitemid 10046626)
14. Cavanagh, J. B. (1999) Corpora-amylacea and the family of polyglucosan diseases. Brain Res. Brain Res. Rev. 29, 265-295
15. Lafora, G. R., and Glueck, B. (1911) Beitrag zur Histopathologie der myoklonischen Epilepsie. Z. Gesamte Neurol. Psy. 6, 1-14
16. Van Heycop Ten Ham, M. (1975) Lafora Disease, a Form of Progressive Myoclonus Epilepsy, Elsevier, Amsterdam
17. Turnbull, J., DePaoli-Roach, A. A., Zhao, X., Cortez, M. A., Pencea, N., Tiberia, E., Piliguian, M., Roach, P. J., Wang, P., Ackerley, C. A., and Minassian, B. A. (2011) PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet. 7, e1002037
18. Chan, E. M., Young, E. J., Ianzano, L., Munteanu, I., Zhao, X., Christopoulos, C. C., Avanzini, G., Elia, M., Ackerley, C. A., Jovic, N. J., Bohlega, S., Andermann, E., Rouleau, G. A., Delgado-Escueta, A. V., Minassian, B. A., and Scherer, S. W. (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat. Genet. 35, 125-127 (Pubitemid 37187629)
19. Dubey, D., and Ganesh, S. (2008) Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy. Hum. Mol. Genet. 17, 3010-3020
20. Gentry, M. S., Worby, C. A., and Dixon, J. E. (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl. Acad. Sci. U.S.A. 102, 8501-8506 (Pubitemid 40862765)
21. Lohi, H., Ianzano, L., Zhao, X. C., Chan, E. M., Turnbull, J., Scherer, S. W., Ackerley, C. A., and Minassian, B. A. (2005) Novel glycogen synthase kinase-3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum. Mol. Genet. 14, 2727-2736 (Pubitemid 41300645)
22. Vilchez, D., Ros, S., Cifuentes, D., Pujadas, L., Vallès, J., García-Fojeda, B., Criado-García, O., Fernández- Sánchez, E., Medraño-Fernández, I., Domínguez, J., García-Rocha, M., Soriano, E., Rodríguez de Córdoba, S., and Guinovart, J. J. (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat. Neurosci. 10, 1407-1413 (Pubitemid 350014686)
23. Couarch, P., Vernia, S., Gourfinkel-An, I., Lesca, G., Gataullina, S., Fedirko, E., Trouillard, O., Depienne, C., Dulac, O., Steschenko, D., Leguern, E., Sanz, P., and Baulac, S. (2011) Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism. J. Mol. Med. 89, 915-925
24. Vernia, S., Solaz-Fuster, M. C., Gimeno-Alcañiz, J. V., Rubio, T., García-Haro, L., Foretz, M., de Córdoba, S. R., and Sanz, P. (2009) AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase-1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex. J. Biol. Chem. 284, 8247-8255
25. Worby, C. A., Gentry, M. S., and Dixon, J. E. (2008) Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG). J. Biol. Chem. 283, 4069-4076
26. DePaoli-Roach, A. A., Tagliabracci, V. S., Segvich, D. M., Meyer, C. M., Irimia, J. M., and Roach, P. J. (2010) Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J. Biol. Chem. 285, 25372-25381
27. Tagliabracci, V. S., Turnbull, J., Wang, W., Girard, J. M., Zhao, X., Skurat, A. V., Delgado-Escueta, A. V., Minassian, B. A., Depaoli-Roach, A. A., and Roach, P. J. (2007) Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo. Proc. Natl. Acad. Sci. U.S.A. 104, 19262-19266
28. Turnbull, J., Wang, P., Girard, J. M., Ruggieri, A., Wang, T. J., Draginov, A. G., Kameka, A. P., Pencea, N., Zhao, X., Ackerley, C. A., and Minassian, B. A. (2010) Glycogen hyperphosphorylation underlies Lafora body formation. Ann. Neurol. 68, 925-933
29. Valles-Ortega, J., Duran, J., Garcia-Rocha, M., Bosch, C., Saez, I., Pujadas, L., Serafin, A., Cañas, X., Soriano, E., Delgado-García, J. M., Gruart, A., and Guinovart, J. J. (2011) Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol. Med. 3, 667-681
30. Ganesh, S., Delgado-Escueta, A. V., Sakamoto, T., Avila, M. R., Machado- Salas, J., Hoshii, Y., Akagi, T., Gomi, H., Suzuki, T., Amano, K., Agarwala, K. L., Hasegawa, Y., Bai, D. S., Ishihara, T., Hashikawa, T., Itohara, S., Cornford, E. M., Niki, H., and Yamakawa, K. (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy, and impaired behavioral response in mice. Hum. Mol. Genet. 11, 1251-1262 (Pubitemid 34555522)
31. Nielsen, J. N., Derave, W., Kristiansen, S., Ralston, E., Ploug, T., and Richter, E. A. (2001) Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content. J. Physiol. 531, 757-769 (Pubitemid 32243753)
32. Baba, O. (1993) Production of monoclonal antibody that recognizes glycogen and its application for immunohistochemistry. Kokubyo Gakkai Zasshi 60, 264-287
33. Krisman, C. R. (1962) A method for the colorimetric estimation of glycogen with iodine. Anal. Biochem. 4, 17-23
34. Girard, J. M., Lê, K. H., and Lederer, F. (2006) Molecular characterization of laforin, a dual specificity protein phosphatase implicated in Lafora disease. Biochimie 88, 1961-1971 (Pubitemid 44895567)
35. Wang, W., Parker, G. E., Skurat, A. V., Raben, N., DePaoli-Roach, A. A., and Roach, P. J. (2006) Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Biochem. Biophys. Res. Commun. 350, 588-592 (Pubitemid 44547888)
36. Fernández-Sánchez, M. E., Criado-García, O., Heath, K. E., García-Fojeda, B., Medraño-Fernández, I., Gomez-Garre, P., Sanz, P., Serratosa, J. M., and Rodríguez de Córdoba, S. (2003) Laforin, the dual phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation. Hum. Mol. Genet. 12, 3161-3171
37. Ganesh, S., Tsurutani, N., Suzuki, T., Hoshii, Y., Ishihara, T., Delgado-Escueta, A. V., and Yamakawa, K. (2004) The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. 313, 1101-1109 (Pubitemid 38050106)
38. Wang, W., and Roach, P. J. (2004) Glycogen and related polysaccharides inhibit the laforin dual specificity protein phosphatase. Biochem. Biophys. Res. Commun. 325, 726-730 (Pubitemid 39487932)
39. Pérez, S., and Bertoft, E. (2010) The molecular structures of starch components and their contribution to the architecture of starch granules: a comprehensive review. Starch-Stärke 62, 389-420
40. Criado, O., Aguado, C., Gayarre, J., Duran-Trio, L., Garcia-Cabrero, A. M., Vernia, S., San Millán, B., Heredia, M., Romá-Mateo, C., Mouron, S., Juana-López, L., Domínguez, M., Navarro, C., Serratosa, J. M., Sanchez, M., Sanz, P., Bovolenta, P., Knecht, E., and Rodriguez de Cordoba, S. (2012) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum. Mol. Genet. 21, 1521-1533